Advertisement
Screener

ICU MEDICAL INC/DE (ICUI) Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)

2.2 / 5 stars · 52/120 Roast Me

ICU MEDICAL INC/DE Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)

ICU MEDICAL INC/DE (ICUI) reported Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) of -$5.40 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.

Financial Statements › Income Statement › Other Income

us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss · last filed 2025-02-27

  • ICU MEDICAL INC/DE fair value, liability, recurring basis, still held, unrealized gain (loss) for the quarter ending 2024-03-31 was -$295.00K, a 142.14% decline year-over-year.
  • ICU MEDICAL INC/DE fair value, liability, recurring basis, still held, unrealized gain (loss) for the quarter ending 2023-03-31 was $700.00K.
  • ICU MEDICAL INC/DE fair value, liability, recurring basis, still held, unrealized gain (loss) for the quarter ending 2022-06-30 was $27.19M.
  • ICU MEDICAL INC/DE fair value, liability, recurring basis, still held, unrealized gain (loss) for the quarter ending 2021-09-30 was -$3.10M.
  • ICU MEDICAL INC/DE fair value, liability, recurring basis, still held, unrealized gain (loss) for fiscal 2024 was -$5.40M.
  • ICU MEDICAL INC/DE fair value, liability, recurring basis, still held, unrealized gain (loss) for fiscal 2023 was -$16.25M.
  • ICU MEDICAL INC/DE fair value, liability, recurring basis, still held, unrealized gain (loss) for fiscal 2022 was -$32.09M.
  • ICU MEDICAL INC/DE fair value, liability, recurring basis, still held, unrealized gain (loss) for fiscal 2020 was $9.00M.
Period endFair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) 3 monthFair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) 6 monthFair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) 9 monthFair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) 12 month
2024-12-31-$5.40M
10-K · filed 2025-02-27
2024-03-31-$295.00K
10-Q · filed 2024-11-12
2023-12-31-$16.25M
10-K · filed 2025-02-27
2023-03-31$700.00K
10-Q · filed 2024-11-12
2022-12-31-$32.09M
10-K · filed 2024-02-27
2022-06-30$27.19M
10-Q · filed 2022-08-09
2021-09-30-$3.10M
10-Q · filed 2021-11-05
-$3.10M
derived: sum of 2 quarters · filed 2021-11-05
-$3.10M
derived: sum of 3 quarters · filed 2021-11-05
2021-06-30$0.00
10-Q · filed 2021-11-05
$0.00
derived: sum of 2 quarters · filed 2021-11-05
2021-03-31$0.00
10-Q · filed 2021-11-05
2020-12-31$9.00M
10-K · filed 2022-02-25
2020-03-31$0.00
10-Q · filed 2020-05-08
-$94.80M
derived: sum of 2 quarters · filed 2022-02-25
-$94.60M
derived: sum of 3 quarters · filed 2022-02-25
-$55.10M
derived: sum of 4 quarters · filed 2022-02-25
2019-12-31-$94.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
-$94.60M
derived: sum of 2 quarters · filed 2022-02-25
-$55.10M
derived: sum of 3 quarters · filed 2022-02-25
-$47.40M
10-K · filed 2022-02-25
2019-09-30$200.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$39.70M
derived: sum of 2 quarters · filed 2019-11-12
$47.40M
10-Q · filed 2019-11-12
$47.30M
derived: sum of 4 quarters · filed 2021-02-26
2019-06-30$39.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
$47.20M
10-Q · filed 2019-08-09
$47.10M
derived: sum of 3 quarters · filed 2021-02-26
$65.60M
derived: sum of 4 quarters · filed 2021-02-26
2019-03-31$7.70M
10-Q · filed 2020-05-08
$7.60M
derived: sum of 2 quarters · filed 2021-02-26
$26.10M
derived: sum of 3 quarters · filed 2021-02-26
$32.10M
derived: sum of 4 quarters · filed 2021-02-26
2018-12-31-$100.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26
$18.40M
derived: sum of 2 quarters · filed 2021-02-26
$24.40M
derived: sum of 3 quarters · filed 2021-02-26
$20.40M
10-K · filed 2021-02-26
2018-09-30$18.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09
$24.50M
derived: sum of 2 quarters · filed 2018-11-09
$20.50M
10-Q · filed 2018-11-09
$15.50M
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30$6.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$2.00M
10-Q · filed 2018-08-09
-$3.00M
derived: sum of 3 quarters · filed 2020-03-02
$4.00M
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31-$4.00M
10-Q · filed 2018-05-10
-$9.00M
derived: sum of 2 quarters · filed 2020-03-02
-$2.00M
derived: sum of 3 quarters · filed 2020-03-02
2017-12-31-$5.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
$2.00M
derived: sum of 2 quarters · filed 2020-03-02
$8.00M
10-K · filed 2020-03-02
2017-09-30$7.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$13.00M
10-Q · filed 2017-11-09
2017-06-30$6.00M
10-Q · filed 2017-08-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Heartflow, Inc. (HTFL)United States$4.225B
PULSE BIOSCIENCES, INC. (PLSE)United States$3.696B-24.47
iRhythm Holdings, Inc. (IRTC)United States$3.651B-281.06
HAEMONETICS CORP (HAE)United States$4.821B36.52
TELEFLEX INC (TFX)United States$5.093B-5.44
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
AtriCure, Inc. (ATRC)United States$3.089B
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55